Shopping Cart 0
Cart Subtotal
USD 0

Concept Life Sciences Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Single User License
USD 250

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Site License
USD 500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Download Option: Yes
Deliverable Format : Excel, PDF viewable on the website via username

Corporate User License
USD 750

Details

Summary

Concept Life Sciences Ltd (Concept Life Sciences), formerly Peakdale Molecular Ltd, a subsidiary of Concept Life Sciences Holdings Ltd is a provider of integrated discovery and development solution. The company services include integrated drug discovery and development services and analytical services. its analytical services include life sciences, food and consumer services, industrial and environmental services, chemicals and online reporting. The company caters its services to pharmaceutical, biotechnology, petrochemical, agrochemical, chemical and consumer products industries. It has operations across the UK. Concept Life Sciences is headquartered in Manchester, the UK.

Concept Life Sciences Ltd-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Concept Life Sciences Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Concept Life Sciences Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

Concept Life Sciences Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Concept Life Sciences Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

Concept Life Sciences Ltd, Medical Devices Deals, 2012 to YTD 2018 10

Concept Life Sciences Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

Concept Life Sciences Ltd, Pharmaceuticals & Healthcare, Deal Details 12

Private Equity 12

Equistone Partners Europe Acquires Majority Interest in Concept Life Sciences 12

Partnerships 13

Concept Life Sciences and Alderley Analytical Enter into Partnership 13

Aquila BioMedical Enters into Co-Development Agreement with Macrophage Pharma 14

Metrion Biosciences Enters into Agreement with Concept Life Sciences 15

Acquisition 16

Spectris Acquires Concept Life Sciences for USD232 Million 16

Concept Life Sciences Acquires Aquila BioMedical 17

Concept Life Sciences Acquires CXR Biosciences 18

Concept Life Sciences Acquires Peakdale Molecular 19

Concept Life Sciences Acquires Scientific Analysis Laboratories 20

Concept Life Sciences Acquires Resource and Environmental Consultants 21

Concept Life Sciences Ltd-Key Competitors 22

Concept Life Sciences Ltd-Key Employees 23

Concept Life Sciences Ltd-Locations And Subsidiaries 24

Head Office 24

Other Locations & Subsidiaries 24

Recent Developments 25

Strategy And Business Planning 25

Sep 12, 2017: Concept Life Sciences expands into Alderley Park to support discovery services growth 25

Financial Announcements 26

Dec 18, 2017: Concept Life Sciences Achieves Record Profits and Strengthens Senior Team 26

Corporate Communications 27

Aug 13, 2018: Concept Life Sciences appoints Sarah Harris as East Coast business development director 27

Jun 26, 2018: Concept Life Sciences Names John Vu as West Coast Business Development Director 28

Oct 24, 2017: Concept Life Sciences appoints Philip Payne as Chief Commercial Officer 29

Aug 17, 2017: Concept Life Sciences Announces the Appointment of John Handley as Chief Operating Officer as the Company Prepares for the Next Stage of Growth and Development 30

Aug 03, 2017: Concept Life Sciences Strengthens Senior Management Team 31

Apr 03, 2017: Concept Life Sciences Further Strengthens Its Senior Team 32

Legal and Regulatory 33

Feb 08, 2018: Concept Life Sciences Expands GXP Compliance 33

Other Significant Developments 34

Jul 11, 2018: Concept Life Sciences expands integrated drug development services through FEI registration and investment in additional ICH stability capacity 34

Nov 29, 2017: Concept Life Sciences Invests in East Kilbride Analytical Services Facility 35

Mar 01, 2017: Concept Life Sciences Group Announces Multi-Million Pound Expansion Programme And Rebranding 36

Appendix 37

Methodology 37

About GlobalData 37

Contact Us 37

Disclaimer 37


List Of Figure

List of Figures

Concept Life Sciences Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Concept Life Sciences Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Concept Life Sciences Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Concept Life Sciences Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Concept Life Sciences Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7

Concept Life Sciences Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Concept Life Sciences Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

Concept Life Sciences Ltd, Medical Devices Deals, 2012 to YTD 2018 10


List Of Table

List of Tables

Concept Life Sciences Ltd, Pharmaceuticals & Healthcare, Key Facts 2

Concept Life Sciences Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Concept Life Sciences Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

Concept Life Sciences Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Concept Life Sciences Ltd, Deals By Therapy Area, 2012 to YTD 2018 9

Concept Life Sciences Ltd, Medical Devices Deals, 2012 to YTD 2018 10

Concept Life Sciences Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

Equistone Partners Europe Acquires Majority Interest in Concept Life Sciences 12

Concept Life Sciences and Alderley Analytical Enter into Partnership 13

Aquila BioMedical Enters into Co-Development Agreement with Macrophage Pharma 14

Metrion Biosciences Enters into Agreement with Concept Life Sciences 15

Spectris Acquires Concept Life Sciences for USD232 Million 16

Concept Life Sciences Acquires Aquila BioMedical 17

Concept Life Sciences Acquires CXR Biosciences 18

Concept Life Sciences Acquires Peakdale Molecular 19

Concept Life Sciences Acquires Scientific Analysis Laboratories 20

Concept Life Sciences Acquires Resource and Environmental Consultants 21

Concept Life Sciences Ltd, Key Competitors 22

Concept Life Sciences Ltd, Key Employees 23

Concept Life Sciences Ltd, Other Locations 24

Concept Life Sciences Ltd, Subsidiaries 24

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies

Products

Concept Life Sciences Ltd, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

Company Profile

Company Profile Title

Summary

Concept Life Sciences Ltd (Concept Life Sciences), formerly Peakdale Molecular Ltd, a subsidiary of Concept Life Sciences Holdings Ltd is a provider of integrated discovery and development solution. The company services include integrated drug discovery and development services and analytical services. its analytical services include life sciences, food and consumer services, industrial and environmental services, chemicals and online reporting. The company caters its services to pharmaceutical, biotechnology, petrochemical, agrochemical, chemical and consumer products industries. It has operations across the UK. Concept Life Sciences is headquartered in Manchester, the UK.

Concept Life Sciences Ltd-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Scope

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Concept Life Sciences Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Concept Life Sciences Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

Concept Life Sciences Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Concept Life Sciences Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

Concept Life Sciences Ltd, Medical Devices Deals, 2012 to YTD 2018 10

Concept Life Sciences Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

Concept Life Sciences Ltd, Pharmaceuticals & Healthcare, Deal Details 12

Private Equity 12

Equistone Partners Europe Acquires Majority Interest in Concept Life Sciences 12

Partnerships 13

Concept Life Sciences and Alderley Analytical Enter into Partnership 13

Aquila BioMedical Enters into Co-Development Agreement with Macrophage Pharma 14

Metrion Biosciences Enters into Agreement with Concept Life Sciences 15

Acquisition 16

Spectris Acquires Concept Life Sciences for USD232 Million 16

Concept Life Sciences Acquires Aquila BioMedical 17

Concept Life Sciences Acquires CXR Biosciences 18

Concept Life Sciences Acquires Peakdale Molecular 19

Concept Life Sciences Acquires Scientific Analysis Laboratories 20

Concept Life Sciences Acquires Resource and Environmental Consultants 21

Concept Life Sciences Ltd-Key Competitors 22

Concept Life Sciences Ltd-Key Employees 23

Concept Life Sciences Ltd-Locations And Subsidiaries 24

Head Office 24

Other Locations & Subsidiaries 24

Recent Developments 25

Strategy And Business Planning 25

Sep 12, 2017: Concept Life Sciences expands into Alderley Park to support discovery services growth 25

Financial Announcements 26

Dec 18, 2017: Concept Life Sciences Achieves Record Profits and Strengthens Senior Team 26

Corporate Communications 27

Aug 13, 2018: Concept Life Sciences appoints Sarah Harris as East Coast business development director 27

Jun 26, 2018: Concept Life Sciences Names John Vu as West Coast Business Development Director 28

Oct 24, 2017: Concept Life Sciences appoints Philip Payne as Chief Commercial Officer 29

Aug 17, 2017: Concept Life Sciences Announces the Appointment of John Handley as Chief Operating Officer as the Company Prepares for the Next Stage of Growth and Development 30

Aug 03, 2017: Concept Life Sciences Strengthens Senior Management Team 31

Apr 03, 2017: Concept Life Sciences Further Strengthens Its Senior Team 32

Legal and Regulatory 33

Feb 08, 2018: Concept Life Sciences Expands GXP Compliance 33

Other Significant Developments 34

Jul 11, 2018: Concept Life Sciences expands integrated drug development services through FEI registration and investment in additional ICH stability capacity 34

Nov 29, 2017: Concept Life Sciences Invests in East Kilbride Analytical Services Facility 35

Mar 01, 2017: Concept Life Sciences Group Announces Multi-Million Pound Expansion Programme And Rebranding 36

Appendix 37

Methodology 37

About GlobalData 37

Contact Us 37

Disclaimer 37


List Of Figure

List of Figures

Concept Life Sciences Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Concept Life Sciences Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Concept Life Sciences Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Concept Life Sciences Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Concept Life Sciences Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7

Concept Life Sciences Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Concept Life Sciences Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

Concept Life Sciences Ltd, Medical Devices Deals, 2012 to YTD 2018 10


List Of Table

List of Tables

Concept Life Sciences Ltd, Pharmaceuticals & Healthcare, Key Facts 2

Concept Life Sciences Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Concept Life Sciences Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

Concept Life Sciences Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Concept Life Sciences Ltd, Deals By Therapy Area, 2012 to YTD 2018 9

Concept Life Sciences Ltd, Medical Devices Deals, 2012 to YTD 2018 10

Concept Life Sciences Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

Equistone Partners Europe Acquires Majority Interest in Concept Life Sciences 12

Concept Life Sciences and Alderley Analytical Enter into Partnership 13

Aquila BioMedical Enters into Co-Development Agreement with Macrophage Pharma 14

Metrion Biosciences Enters into Agreement with Concept Life Sciences 15

Spectris Acquires Concept Life Sciences for USD232 Million 16

Concept Life Sciences Acquires Aquila BioMedical 17

Concept Life Sciences Acquires CXR Biosciences 18

Concept Life Sciences Acquires Peakdale Molecular 19

Concept Life Sciences Acquires Scientific Analysis Laboratories 20

Concept Life Sciences Acquires Resource and Environmental Consultants 21

Concept Life Sciences Ltd, Key Competitors 22

Concept Life Sciences Ltd, Key Employees 23

Concept Life Sciences Ltd, Other Locations 24

Concept Life Sciences Ltd, Subsidiaries 24

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products

Concept Life Sciences Ltd, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.